It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.

virus

2591 Results 高级搜索

Viral Safety - Risk Calculator | Biopharmaceutical Manufacturing | {Hcompany}
The Virus Risk Calculator tool is an algorithm to quantify the risk of virus contamination from animal-component free raw materials.
Continuous In-Line Virus Inactivation Bioprocessing | Merck
BioContinuum™ Virus Inactivation Platform: virus inactivation with low pH, a critical virus reduction step in mAb downstream processing.
Virus Inactivation | Biopharmaceutical Manufacturing | Merck
Merck offers raw materials for solvent and detergent treatment, pasteurization and low pH treatment to enable effective virus inactivation.
Viresolve® Barrier Filters | Biopharmaceutical Manufacturing |Merck
Effective bioreactor protection that enhances your overall risk mitigation strategy.
Virus Safety | Biopharmaceutical Manufacturing | Merck
Explore our areas including our Virus Filtration products, to see how we can help ensure viral safety.
Virus filtration process development and validation: best practices | Virus Safety | Merck
Virus filtration process development and validation: best practices
Virus Filtration | Upstream Processing | Biopharmaceutical Manufacturing | Merck
Our new Viresolve® Barrier filters are designed for high-flux filtration of chemically-defined cell culture media and high retention of virus, mycoplasma, and bacteria, including spirochetes.
Viresolve® Pro Virus Filtration Solution | Biopharmaceutical Manufacturing | Merck
Bringing you the latest technology for your virus filtration challenges.
Introducing Centinel™ Intelligent Virus Defense | Merck
Centinel™ Intelligent Virus Defense, the first commercially available gene-editing tool to confer viral resistance to CHO cell lines.
Press Release: Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
Merck today launched a first-of-its-kind gene editing technology to modify CHO cell lines to be resistant to minute virus of mice (MVM), a common contamination threat that remains despite the shift to chemically defined, animal component-free manufacturing processes.